Telehealth GLP-1 Providers That Require Real Doctor Visits

There's a spectrum of GLP-1 telehealth models. At one end, you fill out a form and get a prescription without ever seeing a human face. At the other end, you have a video consultation with a licensed physician who asks questions, reviews your history, and makes a clinical judgment in real time.

Both models are legal. But they are not equivalent, and understanding the difference matters for your safety.

Questionnaire-Only vs. Real Doctor Visit

Most GLP-1 telehealth platforms fall into one of two categories:

Asynchronous (questionnaire-only): You fill out a health questionnaire. A provider reviews it — sometimes in minutes — and approves or denies your prescription without a live conversation. This model prioritizes speed and convenience. The trade-off is that nuanced medical situations can be missed when the entire interaction is text-based.

Synchronous (real-time consultation): You have a live video or phone appointment with a licensed prescriber. They ask follow-up questions, discuss your medical history in context, and make a prescribing decision with the benefit of real-time interaction. This takes longer to schedule but provides a more thorough clinical evaluation.

Why It Matters

A questionnaire can ask whether you have a history of medullary thyroid carcinoma. But it can't follow up when you answer "I'm not sure — my mom had thyroid surgery but I don't know the type." A live physician can probe that answer, recommend you check with your family, and hold the prescription until the question is resolved.

Similarly, questionnaires typically ask "are you taking any medications?" but don't contextualize the answer. A live provider can discuss timing adjustments for levothyroxine, flag potential interactions, and coordinate with your other doctors in a way that a checkbox form cannot.

Which States Require Video Visits?

Telehealth prescribing laws vary by state. Some states require at least one synchronous encounter (video or phone) before a controlled substance or weight-loss medication can be prescribed. Others allow fully asynchronous prescribing for GLP-1 medications (which are not controlled substances in most states). Your provider should know your state's requirements — if they don't mention it, that's worth asking about.

Providers That Require Real Doctor Interaction

Our Recommendation

For first-time GLP-1 patients, we recommend choosing a provider that includes at least one real-time clinical interaction — even if it's a brief video call. The convenience difference between a questionnaire and a 15-minute video consultation is small. The safety difference can be significant.

If you've been on GLP-1 medication for months and are simply refilling through a provider switch, an asynchronous model is more reasonable — you've already been through the initial screening and know your body's response. But for your first prescription, talk to a real person.